Evaluation of the in-vitro activity of Sch 29482.
D000284:Administration, Oral; D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D004285:Dogs; D004352:Drug Resistance, Microbial; D007279:Injections, Subcutaneous; D007700:Kinetics; D007769:Lactams / Q000378:metabolism; D008297:Male; D051379:Mice; D012453:Saimiri; D013045:Species Specificity
D000900:Anti-Bacterial Agents; D007769:Lactams; C033922:Sch 29482